Analysis of the therapeutic basis of cannabis and its application in medicine
DOI:
https://doi.org/10.56294/saludcyt2024937Keywords:
Cannabinoids, Endocannabinoid System, Cannabis, Antitumor Effect, Immune StimulationAbstract
This review compiles information on the therapeutic applications of cannabinoids as a basis for their application in medicine as a treatment strategy. The main objective of this review was to analyze the therapeutic benefits of cannabinoids such as: pain relief, antitumor effect, cell cycle regulation and immune stimulation. Information was compiled from various scientific databases, such as PubMed, BioCell, Scielo, Elsevier, Redalyc, MDPI, PLOS, JAFC, BJPS and Medicinal Chemistry Research, searching by keywords and selecting according to the inclusion criteria. It was possible to identify the therapeutic potential of those that endorse their interaction in receptors, thus the remarkable antitumor effect, pain relief and immune stimulation. However, the effectiveness of cannabis products varies according to the stage of the disease and dosage. It was concluded that the endocannabinoid system (ECS) offers important therapeutic activities for some diseases, whose molecular mechanisms of action have been assessed in different experimental models. The clinical applications of cannabis have been documented in several pathologies such as: cancer, epilepsy, glaucoma, arthritis, asthma, Alzheimer, Crohn, sclerosis, insomnia and Parkinson, the current legislation has opened the way for its industrial production and therapeutic use under the control of regulatory entities
References
1. Observatorio Europeo de la drogas y toxicología. Uso médico del cannabis y los cannabinoides [Internet]. 1st ed. Oficina de Publicaciones de la Unión Europea L, editor. Vol. 1. Lisboa: https://www.emcdda.europa.eu/system/files/publications/10171/20185584_TD0618186ESN_PDF.pdf; 2019 [cited 2023 Mar 27]. 1–52 p. Available from: https://www.emcdda.europa.eu/system/files/publications/10171/20185584_TD0618186ESN_PDF.pdf
2. Dariš B, Tancer Verboten M, Knez Ž, Ferk P. Cannabinoids in cancer treatment: Therapeutic potential and legislation. Bosn J Basic Med Sci. 2019 Feb 12;19(1):14–23.
3. De Janon Quevedo L. Cannabis y medicina tradicional: libertad, sociabilidad y subsidiariedad de este tipo de fitoterapia. In: Bioética UCA Argentina. 2015. p. 1–19.
4. Mosquera J. MARIHUANA - CANNABIS ASPECTOS TOXICOLÓGICOS, CLÍNICOS, SOCIALES Y POTENCIALES USOS TERAPÉUTICOS. Bogotá - Colombia; 2000. 362 p.
5. Cáceres Guido P. Cannabis medicinal: más allá del mito, solo otra droga (vegetal). Salud Colect. 2022 May 6;18:e4078.
6. Onaivi ES. Cannabinoid Receptors in Brain. In 2009 [cited 2023 Mar 8]. p. 335–69. Available from: https://pubmed.ncbi.nlm.nih.gov/19897083/
7. FREUND TF, KATONA I, PIOMELLI D. Role of Endogenous Cannabinoids in Synaptic Signaling. Physiol Rev. 2003 Jul;83(3):1017–66.
8. Tang X, Liu Z, Li X, Wang J, Li L. Cannabinoid Receptors in Myocardial Injury: A Brother Born to Rival. Int J Mol Sci. 2021 Jun 26;22(13):6886.
9. National Institute on drug abuse. página web. 2019. p. 1–10 National Institutes of Health.
10. Romero-Torres BM, Alvarado-Ramírez YA, Duran-Alonzo SR, Ruiz-Contreras AE, Herrera-Solis A, Amancio-Belmont O, et al. A potential role of hippocampus on impulsivity and alcohol consumption through CB1R. Pharmacol Biochem Behav. 2023 Apr;225:173558.
11. Gould J. Cannabis: 4 big questions. Nature. 2015 Sep 23;525(7570):S18–S18.
12. ElSohly MA, Radwan MM, Gul W, Chandra S, Galal A. Phytochemistry of Cannabis sativa L. In 2017. p. 1–36.
13. Sociedad Española del Dolor. Cannabis en el tratamiento del dolor: consideraciones clínicas y de investigación. Scielo. 2017 Feb 1;1(24).
14. Herrero Trujillano M. Medical cannabis and cancer: benefits for cancer pain and other related symptoms. Revista de la Sociedad Española del Dolor. 2022;29:14–9.
15. Abrams DI. Cannabis, Cannabinoids and Cannabis-Based Medicines in Cancer Care. Integr Cancer Ther. 2022 Jan 26;21:153473542210817.
16. Tajik T, Baghaei K, Moghadam VE, Farrokhi N, Salami SA. Extracellular vesicles of cannabis with high CBD content induce anticancer signaling in human hepatocellular carcinoma. Biomedicine & Pharmacotherapy. 2022 Aug;152:113209.
17. Zuñiga Mario; López Alberto. Terapia antitumoral con el uso de cannabinoides, un descubrimiento que podría cambiar la evolución del cáncer. Elseiver [Internet]. 2014 [cited 2023 Oct 14];13(4):244–51. Available from: https://www.elsevier.es/es-revista-gaceta-mexicana-oncologia-305-articulo-terapia-antitumoral-con-el-uso-X1665920114579076
18. Avello MPEFPCP. Potencial uso terapéutico de cannabis. Rev Médica Chile [Internet]. 2017 Aug 26 [cited 2023 Oct 11];1:360–7. Available from: https://scielo.conicyt.cl/pdf/rmc/v145n3/art10.pdf
19. Guggisberg J, Schumacher M, Gilmore G, Zylla DM. Cannabis as an Anticancer Agent: A Review of Clinical Data and Assessment of Case Reports. Cannabis Cannabinoid Res. 2022 Feb 1;7(1):24–33.
20. Kikiowo B, Ogunleye AJ, Iwaloye O, Ijatuyi TT, Adelakun NS, Alashe WO. Induced Fit Docking and Automated QSAR Studies Reveal the ER-α Inhibitory Activity of Cannabis sativa in Breast Cancer. Recent Pat Anticancer Drug Discov. 2021 May;16(2):273–84.
21. Tomko AM, Whynot EG, O’Leary LF, Dupré DJ. Anti-cancer potential of cannabis terpenes in a Taxol-resistant model of breast cancer. Can J Physiol Pharmacol. 2022 Aug 1;100(8):806–17.
22. BIMONTE S, PALMA G, CASCELLA M, CUOMO A. Phytocannabinoids in Triple Negative Breast Cancer Treatment: Current Knowledge and Future Insights. Anticancer Res. 2023 Mar 28;43(3):993–1000.
23. R. Mokoena D, P. George B, Abrahamse H. Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy. Int J Mol Sci. 2019 Sep 26;20(19):4771.
24. Schoeman R, de la Harpe A, Beukes N, Frost CL. Cannabis with breast cancer treatment: propitious or pernicious? 3 Biotech. 2022 Feb 1;12(2):54.
25. Singh K, Nassar N, Bachari A, Schanknecht E, Telukutla S, Zomer R, et al. The Pathophysiology and the Therapeutic Potential of Cannabinoids in Prostate Cancer. Cancers (Basel). 2021 Aug 15;13(16):4107.
26. Singh K, Jamshidi N, Zomer R, Piva TJ, Mantri N. Cannabinoids and Prostate Cancer: A Systematic Review of Animal Studies. Int J Mol Sci. 2020 Aug 29;21(17):6265.
27. Mousa A, Petrovic M, Fleshner NE. Prevalence and predictors of cannabis use among men receiving androgen-deprivation therapy for advanced prostate cancer. Canadian Urological Association Journal. 2019 Apr 5;14(1).
28. Barré T, Pol S, Ramier C, Di Beo V, Carrat F, Bureau M, et al. Cannabis Use Is Inversely Associated with Overweight and Obesity in Hepatitis B Virus-Infected Patients (ANRS CO22 Hepather Cohort). Cannabis Cannabinoid Res. 2022 Oct 1;7(5):677–89.
29. Reece AS, Hulse GK. Epidemiological overview of multidimensional chromosomal and genome toxicity of cannabis exposure in congenital anomalies and cancer development. Sci Rep. 2021 Jul 6;11(1):13892.
30. ElTelbany A, Khoudari G, Al-Khadra Y, McCullough A, Alkhouri N. Lower Rates of Hepatocellular Carcinoma Observed Among Cannabis Users: A Population-Based Study. Cureus. 2022 Apr 28;
31. Ghasemiesfe M, Barrow B, Leonard S, Keyhani S, Korenstein D. Association Between Marijuana Use and Risk of Cancer. JAMA Netw Open. 2019 Nov 27;2(11):e1916318.
32. Häuser W, Welsch P, Radbruch L, Fisher E, Bell RF, Moore RA. Cannabis-based medicines and medical cannabis for adults with cancer pain. Cochrane Database of Systematic Reviews. 2023 Jun 5;2023(6).
33. Jett J, Stone E, Warren G, Cummings KM. Cannabis Use, Lung Cancer, and Related Issues. Journal of Thoracic Oncology. 2018 Apr;13(4):480–7.
34. Baumeister SE, Baurecht H, Nolde M, Alayash Z, Gläser S, Johansson M, et al. Cannabis Use, Pulmonary Function, and Lung Cancer Susceptibility: A Mendelian Randomization Study. Journal of Thoracic Oncology. 2021 Jul;16(7):1127–35.
35. BOUABOULA M, RINALDI M, CARAYON P, CARILLON C, DELPECH B, SHIRE D, et al. Cannabinoid-receptor expression in human leukocytes. Eur J Biochem. 1993 May;214(1):173–80.
36. Besser E, Gelfand A, Lewitus GM, Novak‐Kotzer H, Procaccia S, Berman P, et al. Antitumoral effects of cannabis in Notch1 ‐mutated T‐cell acute lymphoblastic leukemia. Cancer Commun. 2023 Jun 21;43(6):711–5.
37. Emhemmed F, Zhao M, Yorulmaz S, Steyer D, Leitao C, Alignan M, et al. Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein. Molecules. 2022 Feb 11;27(4):1214.
38. Sharafi G, He H, Nikfarjam M. Potential Use of Cannabinoids for the Treatment of Pancreatic Cancer. J Pancreat Cancer. 2019 Jan 1;5(1):1–7.
39. chanknecht E, Bachari A, Nassar N, Piva T, Mantri N. Phytochemical Constituents and Derivatives of Cannabis sativa; Bridging the Gap in Melanoma Treatment. Int J Mol Sci. 2023 Jan 3;24(1):859.
40. Naderi J, Dana N, Javanmard S, Amooheidari A, Yahay M, Vaseghi G. Effects of standardized Cannabis sativa extract and ionizing radiation in melanoma cells in vitro. J Cancer Res Ther. 2020;16(6):1495.
41. Bravo Ávalos M, Elizalde Marin Letty, Morales Noriega Adriana. El cannabis como agente terapéutico en Ecuador, repercusión económica contables [Internet]. 2023. Available from: https://orcid.org/0000-0002-3442-0017
42. Wei TT, Chandy M, Nishiga M, Zhang A, Kumar KK, Thomas D, et al. Cannabinoid receptor 1 antagonist genistein attenuates marijuana-induced vascular inflammation. Cell. 2022 May;185(10):1676-1693.e23.
43. Mayorga-Niño F, Torres-Vidales G. Canabinoides y endocanabinoides como herramienta para el desarrollo de posibles antineoplásicos en caninos. Una revisión. Vol. 18. 2014.
44. Muller C, Morales P, Reggio PH. Cannabinoid Ligands Targeting TRP Channels. Front Mol Neurosci. 2019 Jan 15;11.
45. Rojas-Jara C, Polanco-Carrasco R, Cisterna A, Hernández V, Miranda F, Moreno A, et al. Uso medicinal de cannabis: una revisión de la evidencia Medicinal use of cannabis: a review of the evidence. TERAPIA PSICOLÓGICA 2019. 2019;37:166–80.
46. Anaya HJM, Ortiz MPT, Valencia DHF, Ribero OFG. Efficacy of cannabinoids in fibromyalgia: A literature review. Vol. 49, Colombian Journal of Anesthesiology. Sociedad Colombiana de Anestesiología y Reanimación; 2021.
47. Aguado MÁA, Recio EG, de Santiago Moraga J, Nicolás MS. Is medical cannabis useful for the treatment of fibromyalgia? Revista de la Sociedad Española del Dolor. 2022;29:27–31.
48. García Carlos Suero, Banderas Lucia Martín, Holgado María de los Ángeles. Efecto neuroprotector de los cannabinoides en las enfermedades neurodegenerativas. Ars Pharmaceutica [Internet]. 2015 Mar 15 [cited 2023 Oct 14];56(2):77–87. Available from: https://scielo.isciii.es/pdf/ars/v56n2/revision2.pdf
49. Torres C. Uso medicinal de la Marihuana. Scielo. 2019;31(2):10.
50. Chang-Douglass S, Mulvihill C, Pilling S. Cannabis-based medicinal products: summary of NICE guidance. BMJ. 2020 Apr 21;m1108.
51. Koppel BS, Brust JCM, Fife T, Bronstein J, Youssof S, Gronseth G, et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Apr 29;82(17):1556–63.
52. Krcevski‐Skvarc N, Wells C, Häuser W. Availability and approval of cannabis‐based medicines for chronic pain management and palliative/supportive care in Europe: A survey of the status in the chapters of the European Pain Federation. European Journal of Pain. 2018 Mar 13;22(3):440–54.
53. Koppel BS, Brust JCM, Fife T, Bronstein J, Youssof S, Gronseth G, et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014 Apr 29;82(17):1556–63.
54. Chayasirisobhon S. Mechanisms of Action and Pharmacokinetics of Cannabis. Perm J. 2021 Mar;25(1):1–3.
55. Kebede L, Masoomi Dezfooli S, Seyfoddin A. Medicinal cannabis pharmacokinetics and potential methods of delivery. Pharm Dev Technol. 2022 Feb 7;27(2):202–14.
56. Moss DA, Hawks MK, Snyder MJ, Crawford PF. Integrative Medicine: Cannabis and Cannabis-Related Drugs. FP Essent. 2021 Jun;505:28–34.
57. Koltai H, Poulin P, Namdar D. Promoting cannabis products to pharmaceutical drugs. European Journal of Pharmaceutical Sciences. 2019 Apr;132:118–20.
58. Maule WJ. Medical uses of marijuana (Cannabis sativa): fact or fallacy? Br J Biomed Sci. 2015 Jan 4;72(2):85–91.
59. Schmelz M, Häuser W, Hoch E, Petzke F, Sommer C. Cannabisbasierte Arzneimittel. Der Schmerz. 2019 Apr 4;33(2):97–9.
60. Swift W, Coffey C, Degenhardt L, Carlin JB, Romaniuk H, Patton GC. Cannabis and progression to other substance use in young adults: findings from a 13-year prospective population-based study. J Epidemiol Community Health (1978). 2012 Jul;66(7):e26–e26.
61. Poyatos L, Pérez-Acevedo AP, Papaseit E, Pérez-Mañá C, Martin S, Hladun O, et al. Oral Administration of Cannabis and Δ-9-tetrahydrocannabinol (THC) Preparations: A Systematic Review. Medicina (B Aires). 2020 Jun 23;56(6):309.
62. Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018 Nov 7;84(11):2477–82.
63. Amin MR, Ali DW. Pharmacology of Medical Cannabis. Adv Exp Med Biol. 2019;1162:151–65.
64. Lucas CJ, Galettis P, Schneider J. The pharmacokinetics and the pharmacodynamics of cannabinoids. Br J Clin Pharmacol. 2018 Nov 7;84(11):2477–82.
65. Grotenhermen F. Pharmacokinetics and Pharmacodynamics of Cannabinoids. Clin Pharmacokinet. 2003;42(4):327–60.
66. Di Marzo V, Piscitelli F. The Endocannabinoid System and its Modulation by Phytocannabinoids. Neurotherapeutics. 2015 Oct 14;12(4):692–8.
67. Cubillos Sánchez PA. Cannabis for medical and scientific purposes: the Colombian landscape. Colombian Journal of Anesthesiology. 2020 Nov 29;49(2).
68. Llerena Cepeda M de L, Sailema López LK, Zúñiga Cárdenas GA. Variantes de COVID-19 predominates en Ecuador y sus síntomas asociados. Universidad y Sociedad [Internet]. 9jun.2022 [citado 11sep.2023];14(S3):93-04. Available from: https://rus.ucf.edu.cu/index.php/rus/article/view/2939
69. Zúñiga Cárdenas GA, Sailema López LK, Alfonso González I. Pacientes de COVID-19 en cuidados intensivos y sus lesiones cutáneas. Universidad y Sociedad [Internet]. 9jun.2022 [citado 19sep.2023];14(S3):105-17. Available from: https://rus.ucf.edu.cu/index.php/rus/article/view/2940
70. Ramos Serpa G, Gómez Armijos CE, López Falcón A. Aspectos de éticas sobre la vacunación contra el COVID-19. Universidad y Sociedad [Internet]. 9jun.2022 [citado 19sep.2023];14(S3):60-1. Available from: https://rus.ucf.edu.cu/index.php/rus/article/view/2935
Published
Issue
Section
License
Copyright (c) 2024 María Ilusión Solís Sánchez, Shirley Carolina Flores Guillen, Matías Josué Luna Mena, Eliana Camila Puedmag Altamirano (Author)
This work is licensed under a Creative Commons Attribution 4.0 International License.
The article is distributed under the Creative Commons Attribution 4.0 License. Unless otherwise stated, associated published material is distributed under the same licence.
